Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
News + Filings
Holdings
All
13F
13D/G
Other
Sarissa Capital Management LP
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
08/24/2023
SC 13D/A
Sarissa Capital Management LP reports a 5% stake in Alkermes Public Limited Company
06/16/2023
SC 13D/A
Sarissa Capital Management LP has filed a Schedule 13D for Alkermes Public Limited Company
06/12/2023
SC 13D/A
Sarissa Capital Management LP has filed a Schedule 13D for Alkermes Public Limited Company
06/12/2023
SC 13D/A
Sarissa Capital Management LP has filed a Schedule 13D for Alkermes Public Limited Company
05/15/2023
SC 13D/A
Sarissa Capital Management LP reports a 10.5% stake in Innoviva, Inc.
02/28/2023
SC 13D/A
Sarissa Capital Management LP has filed a Schedule 13D for Amarin Corporation plc
02/27/2023
SC 13D/A
Sarissa Capital Management LP has filed a Schedule 13D for Amarin Corporation plc
02/14/2023
SC 13D/A
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
02/10/2023
SC 13D/A
Sarissa Capital Management LP has filed a Schedule 13D for Amarin Corporation plc
02/08/2023
SC 13D/A
Sarissa Capital Management LP reports a 6.2% stake in Amarin Corporation plc
02/06/2023
SC 13D/A
Sarissa Capital Management LP reports a 8.5% stake in Alkermes Public Limited Company
01/19/2023
SC 13D/A
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
01/10/2023
SC 13D/A
Sarissa Capital Management LP reports a 6.2% stake in Amarin Corporation plc
10/11/2022
SC 13D/A
Sarissa Capital Management LP reports a 6% stake in Amarin Corporation plc
10/07/2022
SC 13D/A
Sarissa Capital Management LP reports a 8.6% stake in Alkermes Public Limited Company
07/06/2022
SC 13D/A
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
06/15/2022
SC 13D/A
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
06/03/2022
SC 13D/A
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
01/24/2022
SC 13D
Sarissa Capital Management LP reports a 6.1% stake in Amarin Corporation plc
01/10/2022
SC 13D/A
Sarissa Capital Management LP reports a 8.7% stake in Alkermes Public Limited Company
11/19/2021
SC 13D/A
Sarissa Capital Management LP reports a 8.2% stake in Alkermes Public Limited Company
09/10/2021
SC 13D/A
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
05/27/2021
SC 13D/A
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
05/25/2021
SC 13D/A
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
05/10/2021
SC 13D
Form SC 13D - General statement of acquisition of beneficial ownership:
03/01/2021
SC 13D/A
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
02/12/2021
SC 13D/A
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
01/25/2021
SC 13G
Sarissa Capital Management LP reports a 5% stake in BioCryst Pharmaceuticals, Inc.
01/25/2021
SC 13G
Sarissa Capital Management LP reports a 5.5% stake in Mersana Therapeutics, Inc.
12/14/2020
SC 13D/A
Sarissa Capital Management LP reports a 6.3% stake in Innoviva, Inc.
11/23/2020
SC 13D
Sarissa Capital Management LP reports a 31% stake in Iterum Therapeutics plc
11/09/2020
SC 13D/A
Sarissa Capital Management LP has filed a Schedule 13D for Ironwood Pharmaceuticals, Inc.
02/26/2020
SC 13D/A
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
01/07/2020
SC 13D/A
Sarissa Capital Management LP reports a 0% stake in The Medicines Company
Next >>
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy